Cresco Labs (CRLBF) EBIT Growth (3y) (2023 - 2026)
Cresco Labs (CRLBF) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 273.62% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.84% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 4.63% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 31.70% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 54.58% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 40.87% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -63.87% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 120.38% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -90.87% |
| 10 | Cresco Labs | - | - | 75.45 Mn | 46.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.06% |
| Dec 31, 2025 | 19.25% |
| Sep 30, 2025 | 3.16% |
| Jun 30, 2025 | -10.71% |
| Mar 31, 2025 | -12.47% |
| Dec 31, 2024 | 7.65% |
| Sep 30, 2024 | 28.05% |
| Jun 30, 2024 | 29.61% |
| Mar 31, 2024 | 21.55% |
| Dec 31, 2023 | 335.10% |
| Sep 30, 2023 | -84.90% |
| Jun 30, 2023 | 19.92% |
| Mar 31, 2023 | 28.65% |